Compare QTTB & LAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QTTB | LAND |
|---|---|---|
| Founded | 2015 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 450.1M | 414.1M |
| IPO Year | 2018 | 2010 |
| Metric | QTTB | LAND |
|---|---|---|
| Price | $8.46 | $9.52 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 5 |
| Target Price | ★ $42.25 | $9.33 |
| AVG Volume (30 Days) | ★ 605.5K | 601.8K |
| Earning Date | 11-12-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 5.92% |
| EPS Growth | ★ 136.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $53,737,000.00 | ★ $88,339,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $150.00 | $4.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.66 |
| 52 Week Low | $1.91 | $7.92 |
| 52 Week High | $23.57 | $13.00 |
| Indicator | QTTB | LAND |
|---|---|---|
| Relative Strength Index (RSI) | 24.42 | 53.51 |
| Support Level | $5.12 | $9.10 |
| Resistance Level | $16.85 | $9.73 |
| Average True Range (ATR) | 0.68 | 0.21 |
| MACD | -0.13 | -0.05 |
| Stochastic Oscillator | 5.86 | 32.32 |
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).
Gladstone Land Corp is an externally-managed, agricultural REIT. It is mainly in the business of owning and leasing farmland. It manages operations in one reporting segment: Real Estate Rental Operations. It is focused on the ownership of farms and farm-related properties that are leased on a triple-net basis to tenants with a good operating history and deep farming resources. The farmland is predominantly concentrated in locations where farmers are able to grow either fresh produce or annual row crops (e.g., certain berries and vegetables), which are typically planted and harvested annually, or certain permanent crops (e.g., almonds, blueberries, pistachios, and wine grapes). To a much lesser extent, it also owns farms that grow certain commodity crops (e.g., corn and beans).